Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Arboviruses | 1 | 2018 | 76 | 0.69 | Why? |
| Arbovirus Infections | 1 | 2018 | 104 | 0.65 | Why? |
| Bacteriological Techniques | 1 | 2019 | 239 | 0.64 | Why? |
| Drug Resistance, Microbial | 1 | 2019 | 419 | 0.55 | Why? |
| Multiplex Polymerase Chain Reaction | 3 | 2020 | 1439 | 0.55 | Why? |
| Norovirus | 1 | 2018 | 294 | 0.54 | Why? |
| Molecular Diagnostic Techniques | 4 | 2019 | 4239 | 0.51 | Why? |
| Bacterial Typing Techniques | 2 | 2013 | 273 | 0.50 | Why? |
| Gastroenteritis | 1 | 2018 | 489 | 0.50 | Why? |
| Vomiting | 1 | 2018 | 722 | 0.50 | Why? |
| Minisatellite Repeats | 1 | 2010 | 53 | 0.43 | Why? |
| Electrophoresis, Gel, Pulsed-Field | 1 | 2010 | 78 | 0.43 | Why? |
| Scotland | 9 | 2021 | 1119 | 0.43 | Why? |
| DNA Fingerprinting | 1 | 2010 | 41 | 0.43 | Why? |
| Laboratories | 2 | 2018 | 2858 | 0.41 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2019 | 2309 | 0.40 | Why? |
| Staphylococcal Infections | 3 | 2018 | 1099 | 0.37 | Why? |
| Respiratory Tract Infections | 5 | 2017 | 6817 | 0.37 | Why? |
| Hepatitis C | 2 | 2017 | 1514 | 0.35 | Why? |
| Bacteria | 1 | 2019 | 1897 | 0.35 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 2 | 2013 | 711 | 0.34 | Why? |
| Hepacivirus | 1 | 2017 | 1509 | 0.33 | Why? |
| Virus Diseases | 3 | 2017 | 3779 | 0.31 | Why? |
| Feces | 1 | 2018 | 4235 | 0.27 | Why? |
| Pneumonia | 2 | 2019 | 5652 | 0.26 | Why? |
| Bacterial Infections | 1 | 2017 | 2229 | 0.25 | Why? |
| Real-Time Polymerase Chain Reaction | 4 | 2019 | 11367 | 0.20 | Why? |
| Genotype | 5 | 2018 | 4697 | 0.20 | Why? |
| Drug Resistance, Viral | 2 | 2018 | 1083 | 0.20 | Why? |
| Viral Load | 3 | 2018 | 15850 | 0.19 | Why? |
| Mupirocin | 1 | 2018 | 22 | 0.19 | Why? |
| RNA, Viral | 3 | 2020 | 32276 | 0.18 | Why? |
| Mumps Vaccine | 1 | 2017 | 11 | 0.18 | Why? |
| Mumps virus | 1 | 2017 | 15 | 0.18 | Why? |
| Enterovirus D, Human | 1 | 2018 | 96 | 0.17 | Why? |
| Nose | 2 | 2021 | 1093 | 0.17 | Why? |
| Myelitis | 1 | 2018 | 122 | 0.17 | Why? |
| RNA, Bacterial | 1 | 2017 | 116 | 0.16 | Why? |
| Neisseria gonorrhoeae | 1 | 2018 | 142 | 0.16 | Why? |
| Mumps | 1 | 2017 | 110 | 0.15 | Why? |
| Blood | 1 | 2017 | 274 | 0.15 | Why? |
| Pharynx | 2 | 2021 | 1544 | 0.15 | Why? |
| Enterobacteriaceae | 1 | 2019 | 395 | 0.14 | Why? |
| Gonorrhea | 1 | 2018 | 315 | 0.13 | Why? |
| Enterovirus Infections | 1 | 2018 | 404 | 0.13 | Why? |
| United Kingdom | 6 | 2020 | 18046 | 0.13 | Why? |
| Sensitivity and Specificity | 5 | 2021 | 22971 | 0.12 | Why? |
| Enterobacteriaceae Infections | 1 | 2019 | 529 | 0.12 | Why? |
| Reagent Kits, Diagnostic | 2 | 2018 | 2149 | 0.12 | Why? |
| Community-Acquired Infections | 1 | 2005 | 2328 | 0.12 | Why? |
| beta-Lactamases | 1 | 2019 | 759 | 0.12 | Why? |
| Surgical Wound Infection | 1 | 2018 | 501 | 0.12 | Why? |
| Proline | 1 | 2014 | 345 | 0.11 | Why? |
| Polymerase Chain Reaction | 2 | 2013 | 6740 | 0.11 | Why? |
| Staphylococcus aureus | 1 | 2018 | 844 | 0.11 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2005 | 3388 | 0.11 | Why? |
| Coronavirus | 3 | 2020 | 18339 | 0.11 | Why? |
| Molecular Epidemiology | 2 | 2020 | 1638 | 0.10 | Why? |
| Viral Tropism | 1 | 2018 | 1329 | 0.10 | Why? |
| Measles | 1 | 2018 | 608 | 0.10 | Why? |
| Family Characteristics | 1 | 2021 | 2551 | 0.10 | Why? |
| Bacterial Proteins | 1 | 2019 | 1318 | 0.10 | Why? |
| Oligopeptides | 1 | 2014 | 576 | 0.10 | Why? |
| Communicable Diseases, Imported | 1 | 2018 | 843 | 0.10 | Why? |
| Electrochemical Techniques | 1 | 2013 | 406 | 0.10 | Why? |
| Escherichia coli | 1 | 2017 | 1547 | 0.10 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2021 | 13720 | 0.09 | Why? |
| Drug Resistance, Bacterial | 1 | 2018 | 1414 | 0.09 | Why? |
| Anti-Bacterial Agents | 3 | 2019 | 10083 | 0.09 | Why? |
| Genetic Variation | 2 | 2018 | 3919 | 0.08 | Why? |
| Diagnostic Tests, Routine | 1 | 2019 | 2643 | 0.08 | Why? |
| Disease Outbreaks | 4 | 2020 | 27595 | 0.08 | Why? |
| Humans | 30 | 2021 | 930598 | 0.08 | Why? |
| Virology | 1 | 2010 | 489 | 0.08 | Why? |
| Coronavirus NL63, Human | 1 | 2011 | 669 | 0.07 | Why? |
| Geography | 1 | 2010 | 1801 | 0.07 | Why? |
| Serologic Tests | 1 | 2018 | 4359 | 0.07 | Why? |
| Adenoviruses, Human | 1 | 2005 | 195 | 0.06 | Why? |
| Coronavirus OC43, Human | 1 | 2011 | 1157 | 0.06 | Why? |
| HIV-1 | 1 | 2018 | 3365 | 0.06 | Why? |
| Travel | 2 | 2020 | 7220 | 0.06 | Why? |
| Azithromycin | 1 | 2018 | 3943 | 0.06 | Why? |
| Universities | 1 | 2018 | 4374 | 0.06 | Why? |
| RNA, Messenger | 1 | 2017 | 5131 | 0.06 | Why? |
| Male | 15 | 2021 | 367725 | 0.06 | Why? |
| Middle Aged | 11 | 2021 | 270681 | 0.06 | Why? |
| Students | 2 | 2018 | 5255 | 0.06 | Why? |
| Female | 15 | 2021 | 380317 | 0.06 | Why? |
| Aged | 9 | 2021 | 215776 | 0.06 | Why? |
| Quality Control | 1 | 2005 | 628 | 0.06 | Why? |
| Infant | 5 | 2021 | 30274 | 0.05 | Why? |
| Child, Preschool | 5 | 2021 | 36283 | 0.05 | Why? |
| Point-of-Care Systems | 1 | 2013 | 2955 | 0.05 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.05 | Why? |
| Antibodies, Viral | 4 | 2021 | 51949 | 0.05 | Why? |
| Microbial Sensitivity Tests | 2 | 2019 | 2886 | 0.05 | Why? |
| Hydrolysis | 1 | 2019 | 160 | 0.05 | Why? |
| Adult | 9 | 2021 | 244371 | 0.05 | Why? |
| Cross Protection | 1 | 2021 | 373 | 0.05 | Why? |
| Far East | 1 | 2018 | 125 | 0.04 | Why? |
| Octoxynol | 1 | 2017 | 7 | 0.04 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.04 | Why? |
| Educational Personnel | 1 | 2018 | 76 | 0.04 | Why? |
| RNA Viruses | 1 | 2005 | 824 | 0.04 | Why? |
| High-Throughput Nucleotide Sequencing | 2 | 2020 | 3633 | 0.04 | Why? |
| Seasons | 1 | 2010 | 4071 | 0.04 | Why? |
| Infant, Newborn | 3 | 2021 | 23105 | 0.04 | Why? |
| Measles virus | 1 | 2018 | 194 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Netherlands | 1 | 2005 | 3533 | 0.04 | Why? |
| Mutation Rate | 1 | 2018 | 382 | 0.04 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.04 | Why? |
| Carbapenems | 1 | 2019 | 343 | 0.04 | Why? |
| Genotyping Techniques | 1 | 2018 | 360 | 0.04 | Why? |
| Child | 5 | 2021 | 70012 | 0.04 | Why? |
| Adolescent | 5 | 2018 | 86841 | 0.03 | Why? |
| Hemolysis | 1 | 2017 | 283 | 0.03 | Why? |
| Genome, Bacterial | 1 | 2018 | 446 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.03 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.03 | Why? |
| CD4 Lymphocyte Count | 1 | 2018 | 1517 | 0.03 | Why? |
| Genes, Viral | 1 | 2018 | 1428 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| HIV Infections | 1 | 2018 | 11620 | 0.03 | Why? |
| Nasal Cavity | 1 | 2018 | 909 | 0.03 | Why? |
| Intensive Care Units | 1 | 2019 | 29594 | 0.03 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.03 | Why? |
| Public Health Practice | 1 | 2020 | 945 | 0.03 | Why? |
| Erythrocytes | 1 | 2017 | 617 | 0.03 | Why? |
| Phylogeny | 2 | 2020 | 13341 | 0.03 | Why? |
| Community Health Services | 1 | 2020 | 1000 | 0.03 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.03 | Why? |
| Adenoviridae Infections | 1 | 2011 | 150 | 0.03 | Why? |
| Aging | 1 | 2005 | 3581 | 0.02 | Why? |
| Quality-Adjusted Life Years | 1 | 2011 | 511 | 0.02 | Why? |
| Paramyxoviridae Infections | 1 | 2011 | 364 | 0.02 | Why? |
| Incidence | 1 | 2010 | 25622 | 0.02 | Why? |
| Cross Infection | 1 | 2010 | 8675 | 0.02 | Why? |
| Preoperative Care | 1 | 2018 | 1515 | 0.02 | Why? |
| Bacteremia | 1 | 2019 | 1372 | 0.02 | Why? |
| Phenotype | 1 | 2019 | 4037 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.02 | Why? |
| Neutralization Tests | 1 | 2021 | 6698 | 0.02 | Why? |
| Retrospective Studies | 1 | 2019 | 105322 | 0.02 | Why? |
| Orthopedics | 1 | 2018 | 1279 | 0.02 | Why? |
| Gene Expression | 1 | 2017 | 3332 | 0.02 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.02 | Why? |
| Carrier State | 1 | 2018 | 2100 | 0.02 | Why? |
| Picornaviridae Infections | 1 | 2011 | 544 | 0.02 | Why? |
| England | 1 | 2018 | 5116 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| Anti-HIV Agents | 1 | 2018 | 2209 | 0.02 | Why? |
| Prevalence | 2 | 2021 | 25773 | 0.02 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.02 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.02 | Why? |
| Comorbidity | 1 | 2010 | 34796 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.02 | Why? |
| Schools | 1 | 2021 | 4187 | 0.02 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.02 | Why? |
| Europe | 1 | 2020 | 12702 | 0.02 | Why? |
| Spain | 1 | 2020 | 15545 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2018 | 6551 | 0.01 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2011 | 1234 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.01 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2019 | 8248 | 0.01 | Why? |
| Antiviral Agents | 1 | 2014 | 41703 | 0.01 | Why? |
| Cost of Illness | 1 | 2011 | 1903 | 0.01 | Why? |
| Elective Surgical Procedures | 1 | 2018 | 5338 | 0.01 | Why? |
| Pregnancy | 1 | 2021 | 23879 | 0.01 | Why? |
| Genome, Viral | 1 | 2020 | 13157 | 0.01 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
| Influenza, Human | 1 | 2011 | 10779 | 0.00 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.00 | Why? |
| Severity of Illness Index | 1 | 2011 | 48226 | 0.00 | Why? |
Templeton's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(182)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(180)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_